Medical Marijuana Highs & Lows: Work Comp Clinical and Regulatory Trends

Event Details

When: October 28, 2020 @ 12:00AM EDT On-Demand Where: Online Event Online Event

It seems like every day another state is in the news allowing for medical marijuana and cannabis programs. What ramifications do these state regulations have on workers’ comp? Join us for our annual review of the current regulatory trends and a review of the clinical aspects of marijuana usage along with the potential implications for the work comp industry.

View the Recording

Please note that you can not receive CE credits for watching past webinars.

More stories

Workers' Comp News Release

Risk & Insurance: Starbucks' Workers' Comp Program Earns a Teddy Award for Its Exceptional Employee Advocacy

October 29, 2018

In just four years, Starbucks Coffee Company changed the way workers' comp claims were handled by placing the process in the hands of their p

Mitchell News Release

Montana to Hold Hearing on Proposed Drug Formulary Rule

October 29, 2018

The Montana Department of Labor and Industry (DLI) published draft drug formulary and treatment guideline rules and amendments.

Workers' Comp Blog

The Growing Federal and State Challenges of Medical Marijuana

October 28, 2018

As of October 2018 a total of 29 states and the District of Columbia currently allow for medical marijuana and cannabis programs. What implications does this pose for workers’ compensation? Our latest video covers the current legislative and regulatory trends at the state and federal levels, along with the potential implications for the workers’ compensation industry.

Mitchell Article

Six Key Concepts in Pharmacy Benefit Management

October 24, 2018

The workers' compensation industry can be complex, from keeping up with regulatory changes to understanding the roles and responsibilities of various key stakeholders. Whether you are just starting out in the industry or looking to refresh your knowledge, here are six key concepts to understand about Pharmacy Benefit Management in the workers' compensation industry.

Workers' Comp Article

StateWatch: Bill Review October 2018

October 22, 2018

Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.

Workers' Comp Blog

When are Specialty Drugs, Biologics, and Biosimilars Used in Workers’ Compensation?

October 21, 2018

For workers’ compensation, specialty drugs are prescribed to treat conditions either directly or indirectly related to workplace injuries or illnesses. Directly related conditions, such as HIV and hepatitis, might occur when individuals are exposed to contaminated material (i.e. those working in healthcare or emergency service settings). Indirectly related conditions, such as inflammatory arthritis, are common, and the subsequent work disability and/or potential of being linked to this group of illnesses is significant. Other indirectly related conditions that could be compensable in workers’ compensation are those aggravated by a workplace injury, including multiple sclerosis. The impact specialty drugs will have on workers’ compensation claims will depend largely on the demographics of the insured population.